Discover the latest news from the Pulmonary Hypertension, including advocacy updates, research articles and event coverage.
New Medicaid work requirements take effect in 2027 in most states. See who may need to comply to keep coverage.
Insurance & treatment access | News
Learn about PHA's membership changes: beginning Jan. 1, 2027, key resources will be accessible only to PHA members.
News
Earn up to 20.25 CE/CME credits with 19 new PHA Online University courses, including recordings from the PHA 2026 Conference.
Education | News
PHA thanks Awkwafina for spotlighting pulmonary hypertension on ABC’s Who Wants to Be a Millionaire to millions nationwide.
News
PH Insights returns for Season 3 with six video episodes and a medical advisory team bringing clinical insights to patient stories.
News
Study results using 3D imaging reveal how TBX4 mutations may drive pediatric pulmonary hypertension, led by PHA grantee Ripla Arora.
News
The settlement follows a September 2026 federal court ruling in favor of United Therapeutics regarding two patent infringement claims related to the use of inhaled treprostinil for PH-ILD. No safety concerns were raised.
The label references trial data that shows the drug as safe and effective for moderate to high-risk PAH.
Pulmovant is enrolling participants in its Phase 3 mosliciguat study after positive Phase 2 results.
